July 24, 2012 in Health, Nation/World

In brief: Alzheimer’s drug fails late-stage test

From Wire Reports
 

TRENTON, N.J. – An experimental Alzheimer’s treatment has failed to slow the disease in one late-stage study.

Pfizer, which is testing bapineuzumab with partner Johnson & Johnson, said the injected drug didn’t slow mental or functional decline in patients with mild or moderate Alzheimer’s disease. The study included about 1,100 patients who carry a gene called ApoE4, which gives people a higher risk of developing the memory-robbing disorder.

About half the population does not carry that gene, however, and studies in patients without the gene continue.

Assault victim won’t be charged

LOUISVILLE, Ky. – A Kentucky teenager frustrated by light punishment for two boys who pleaded guilty to sexually assaulting her was spared Monday from having to face a contempt charge for naming them on Twitter in violation of a court order.

The case of Savannah Dietrich, 17, quickly gathered supporters nationwide who were upset that the victim of an assault could be punished for speaking out against her attackers.

On Monday, attorneys for the boys dropped their motion to charge her with contempt.

Get stories like this in a free daily email


Please keep it civil. Don't post comments that are obscene, defamatory, threatening, off-topic, an infringement of copyright or an invasion of privacy. Read our forum standards and community guidelines.

You must be logged in to post comments. Please log in here or click the comment box below for options.

comments powered by Disqus